The CRISPR-Cas9 RB1 inactivation was intentionally left mosaic (<10% of cells) in the starting stem cell populations to more closely mimic the clonal heterogeneity in human retinoblastoma (Fig. 3C and Supplemental Information). The gene discussed is RB1; the disease is retinoblastoma.